Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas

Head and Neck

Volumn 36, Issue 1, 2014, Pages 43-46

  Sohn, Seo Young ^a   Kim, Hye Jeong ^a   Jang, Hye Won ^a   Kim, Sun Wook ^a   Chung, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

papillary thyroid carcinoma; risk factors; thyroid neoplasm; thyroid nodule; TSH

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

PAPILLARY THYROID CARCINOMA; RISK FACTORS; THYROID NEOPLASM; THYROID NODULE; TSH;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROTROPIN; TREATMENT OUTCOME;

EID: 84890437977     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23252     Document Type: Article

References (22)

1. Rojeski MT, Gharib H,. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985; 313: 428-436.
2. Ezzat S, Sarti DA, Cain DR, Braunstein GD,. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154: 1838-1840.
3. Hegedus L,. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351: 1764-1771.
4. Mazzaferri EL,. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559.
5. Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 1989; 121: 197-202.
6. Mazzaferri EL,. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93: 359-362.
7. Kucuk NO, Tari P, Tokmak E, Aras G,. Treatment for microcarcinoma of the thyroid-clinical experience. Clin Nucl Med 2007; 32: 279-281.
8. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ,. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998; 8: 283-289.
9. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA,. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295-4301.
10. Polyzos SA, Kita M, Efstathiadou Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 2008; 134: 953-960.
11. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008; 93: 809-814.
12. Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009; 16: 1251-1260.
13. Jin J, Machekano R, McHenry CR,. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg 2010; 199: 294-298.
14. Gerschpacher M, Gobl C, Anderwald C, Gessl A, Krebs M,. Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid 2010; 20: 389-392.
15. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H,. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009; 71: 434-439.
16. Lim AK, Daykin J, Holder R, Sheppard MC, Franklyn JA,. Measurement of serum TSH in the investigation of patients presenting with thyroid enlargement. QJM 1998; 91: 687-689.
17. Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, Franklyn JA,. Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology. Thyroid 1999; 9: 1105-1109.
18. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H,. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 1996; 131: 187-191.
19. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ,. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112: 1139-1146, discussion 1146-1137.
20. Yamashita H, Noguchi S, Murakami N, et al. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 1999; 86: 842-849.
21. Franco AT, Malaguarnera R, Refetoff S, et al. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci U S A 2011; 108: 1615-1620.
22. Hegedus L, Bonnema SJ, Bennedbaek FN,. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132.